US 9752143
Locked nucleic acid inhibitor of miR-145 and uses thereof
granted A61KA61K31/713A61P
Quick answer
US patent 9752143 (Locked nucleic acid inhibitor of miR-145 and uses thereof) held by MIRAGEN THERAPEUTICS, INC. expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MIRAGEN THERAPEUTICS, INC.
- Grant date
- Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/713, A61P, A61P11/00, A61P43/00